Astrazeneca (AZN) Sales of Property, Plant and Equipment (2009 - 2026)

Astrazeneca (AZN) Sales of Property, Plant and Equipment (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	-
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	29.00 Mn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	-
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	8.00 Mn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	-
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	-
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	-
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	-
9	Novartis Ag	113.45 Bn	113.67 Bn	-	5.00 Mn
10	Biogen	30.87 Bn	26.59 Bn	1.82 Bn	-

Download Data